GRAZI, GIAN LUCA
 Distribuzione geografica
Continente #
EU - Europa 374
NA - Nord America 356
AS - Asia 137
AF - Africa 11
SA - Sud America 4
OC - Oceania 2
Totale 884
Nazione #
US - Stati Uniti d'America 353
IT - Italia 231
SG - Singapore 55
FI - Finlandia 27
CN - Cina 25
IE - Irlanda 24
SE - Svezia 24
IN - India 19
NL - Olanda 17
DE - Germania 15
KR - Corea 9
JP - Giappone 7
ZA - Sudafrica 7
BG - Bulgaria 6
HK - Hong Kong 6
RU - Federazione Russa 6
TW - Taiwan 6
GB - Regno Unito 5
ID - Indonesia 5
FR - Francia 4
IR - Iran 4
TG - Togo 4
LT - Lituania 3
AR - Argentina 2
AU - Australia 2
CA - Canada 2
HU - Ungheria 2
NO - Norvegia 2
PL - Polonia 2
UA - Ucraina 2
AT - Austria 1
BE - Belgio 1
BO - Bolivia 1
EC - Ecuador 1
LI - Liechtenstein 1
MX - Messico 1
PK - Pakistan 1
RO - Romania 1
Totale 884
Città #
Rome 66
Fairfield 41
Singapore 41
Ashburn 36
Chandler 27
Helsinki 27
Dublin 24
Nashville 24
Santa Clara 23
Seattle 20
Woodbridge 17
Wilmington 16
Houston 13
Bologna 10
Vallecorsa 10
Cambridge 8
New York 8
San Paolo di Civitate 8
Amsterdam 7
Ann Arbor 7
Boydton 7
Johannesburg 7
Milan 7
Princeton 7
Boston 6
Parma 6
Sofia 6
Andover 5
Genova 5
Jakarta 5
Naples 5
Bolzano 4
Buk-gu 4
Fremont 4
Lawrence 4
Lomé 4
Teningen 4
Alpharetta 3
Atlanta 3
Delhi 3
Des Moines 3
Gangseo-gu 3
Hong Kong 3
Mascalucia 3
Palermo 3
Perugia 3
The Bronx 3
Verona 3
Bremen 2
Budapest 2
Buenos Aires 2
Bussolengo 2
Columbus 2
Falkenstein 2
Fiuggi 2
Formigine 2
Frankfurt am Main 2
Genoa 2
Hyderabad 2
Livorno 2
London 2
Lucca 2
Millbury 2
Moscow 2
Munich 2
Naha 2
Norwalk 2
Padova 2
Pagani 2
Philadelphia 2
Pittsburgh 2
Romainville 2
Saint-Fons 2
San Diego 2
San Jose 2
Scandicci 2
Shanghai 2
Stjørdal 2
Stockholm 2
Treviso 2
Yongsan-gu 2
Yuncheng 2
Brussels 1
Cerveteri 1
Collegno 1
Corridonia 1
Cuttack 1
Florence 1
Gold Coast 1
Gothenburg 1
Guangzhou 1
Guidonia 1
Handan 1
Islamabad 1
Kairaku 1
Kelvin Grove 1
Kyoto 1
La Paz 1
Latina 1
Lissone 1
Totale 642
Nome #
Transforming growth factor-beta-induced protein as a novel secreted immune check-point in colorectal cancer 157
Italian clinical practice guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 152
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 131
Italian practical clinical guidelines on cholangiocarcinoma: Part II, treatment 101
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 71
Iron capture through CD71 drives perinatal and tumor-associated Treg expansion 66
The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group 39
Laparoscopic Liver Surgery. What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience 28
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 28
REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer 27
null 21
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 20
The effect of a liver transplant program on the outcomes of resectable hepatocellular carcinoma: a nationwide multicenter analysis 19
Robotic Liver Resections: Application of Difficulty Score Systems to an Initial Experience. Is a Specific Robotic Difficulty Score Necessary? 15
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 15
Single large hepatocellular carcinoma > 5 cm with surgical indication: is it mandatory a major hepatectomy? a propensity-score weighted analysis 12
The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist 12
OC.13.3: Metformin Inhibits Proliferation, Enhances Apoptosis and Down-Regulates Epithelial to Mesenchymal Transition (EMT) in Human Cholangiocarcinoma (CCA): A Study on Human Primary Cell Cultures 12
Primary leiomyoma of the liver in an immunocompetent patient 11
The FXR Agonist, Obeticholic Acid, Inhibits the Cancerogenic Potential of Primary Human Cholangiocarcinoma Cells: a Study on Primary Human Cell Cultures 10
Machine learning predictive model to guide treatment allocation for recurrent hepatocellular carcinoma after surgery 10
Is it time to develop a robotic difficulty score system? 7
Metformin reduces cell migration and down-regulates epithelial to mesenchymal transition (EMT) by AMPK/Foxo3a pathway in human intrahepatic cholangiocarcinoma (CCA) 7
Specific human cholangiocarcinoma (CCA) subpopulations of cancer stem cells (CSCs) express DoubleCortin-Like Kinase 1 (DCLK1) and DCLK1 inhibition induces anti-cancer effects 5
OC.08.1 DOUBLECORTIN-LIKE KINASE 1 (DCLK1) IS A MARKER OF SPECIFIC SUBPOPULATIONS OF CANCER STEM CELLS (CSCS) IN HUMAN CHOLANGIOCARCINOMA (CCA) AND ITS INHIBITION EXERTS ANTI-CANCER EFFECTS 4
null 3
null 3
null 3
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 2
Metformin reduces cell migration and down-regulates epithelial to mesenchymal transition by AMPK / Foxo3a pathway in human intrahepatic cholangiocarcinoma 1
Totale 992
Categoria #
all - tutte 3.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021157 0 0 21 12 35 35 0 7 15 17 12 3
2021/2022113 11 2 18 9 9 5 2 10 4 3 19 21
2022/2023180 17 22 6 7 9 9 1 19 54 6 21 9
2023/2024251 13 15 13 49 17 39 13 19 14 22 17 20
2024/2025291 24 33 31 65 100 38 0 0 0 0 0 0
Totale 992